Nivagen Pharmaceuticals, Inc.
Pharmaceutical ManufacturingCalifornia, United States51-200 Employees
Nivagen Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development, acquisition, and sale of generic prescription drugs and over-the-counter products for the North American market. It aims to deliver high-quality products at affordable prices by leveraging global partnerships with FDA-approved manufacturing facilities around the world, focusing on a model that combines development, licensing, and sales services. The firm emphasizes a strategic partnership approach to reduce costs for consumers while creating value across the supply chain, and it actively seeks collaborations with contract research and manufacturing organizations to co-develop products, as well as opportunities to acquire existing ones. Headquartered in Sacramento, California, the company operates within the pharmaceutical manufacturing industry and positions itself as a specialty provider that can offer turnkey solutions to small FDA-qualified manufacturers seeking entry into the U.S. market. Nivagen’s activities include developing and co-developing products, acquiring licenses, and delivering sales and marketing services, with a stated focus on leveraging global alliances to expand its product portfolio. A recent development noted in industry coverage is the acquisition of Nivagen Pharmaceuticals, Inc. by PAI Pharma, supported by Olympus Partners, reflecting ongoing consolidation in the sector.